AI assistant
Sending…
RESMED INC — Director's Dealing 2010
Mar 3, 2010
30071_dirs_2010-03-03_91593178-b167-4dbd-b9f1-608954bf2364.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-03-01
Reporting Person: Farrell Michael J. (Sr. Vice President)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 1 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| ResMed NQ Stock Options | $38.50 | 2016-02-03 | ResMed Common Stock (15000) | Direct | |
| ResMed NQ Stock Options | $46.19 | 2013-11-10 | ResMed Common Stock (17000) | Direct | |
| ResMed NQ Stock Options | $43.42 | 2014-08-01 | ResMed Common Stock (25000) | Direct | |
| ResMed NQ Stock Options | $42.05 | 2014-11-07 | ResMed Common Stock (4000) | Direct | |
| ResMed NQ Stock Options | $43.35 | 2015-10-01 | ResMed Common Stock (10000) | Direct | |
| ResMed NQ Stock Options | $31.04 | 2015-11-20 | ResMed Common Stock (55000) | Direct |
Footnotes
F1: Options vest 1/4 annually on the anniversary of the grant. Represents date options first became exercisable.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Regulatory Filings
2026
Jan 29